1. Home
  2. EFTR

EFTR

eFFECTOR Therapeutics Inc.

Logo eFFECTOR Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-15-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

Founded: 2012 Country:
United States
United States
Employees: N/A City: SOLANA BEACH
Market Cap: 7.7M IPO Year: N/A
Target Price: $112.17 AVG Volume (30 days): 373.2K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -16.37 EPS Growth: N/A
52 Week Low/High: $2.03 - $37.00 Next Earning Date: 05-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: